Correlation Between FrontView REIT, and Capital Nasdaq

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Capital Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Capital Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and Capital Nasdaq Biotechnology, you can compare the effects of market volatilities on FrontView REIT, and Capital Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Capital Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Capital Nasdaq.

Diversification Opportunities for FrontView REIT, and Capital Nasdaq

-0.03

Correlation Coefficient

FrontView REIT,  Capital Nasdaq

Good diversification

The 3 months correlation between FrontView and Capital is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Capital Nasdaq Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capital Nasdaq Biote and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Capital Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capital Nasdaq Biote has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Capital Nasdaq go up and down completely randomly.

Pair Corralation between FrontView REIT, and Capital Nasdaq

Considering the 90-day investment horizon FrontView REIT, is expected to under-perform the Capital Nasdaq. In addition to that, FrontView REIT, is 2.0 times more volatile than Capital Nasdaq Biotechnology. It trades about -0.21 of its total potential returns per unit of risk. Capital Nasdaq Biotechnology is currently generating about 0.01 per unit of volatility. If you would invest  2,821  in Capital Nasdaq Biotechnology on December 30, 2024 and sell it today you would earn a total of  16.00  from holding Capital Nasdaq Biotechnology or generate 0.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	91.94%
Values	Daily Returns

FrontView REIT,  vs.  Capital Nasdaq Biotechnology

FrontView REIT,

Risk-Adjusted Performance

Very Weak

Over the last 90 days FrontView REIT, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Capital Nasdaq Biote

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Capital Nasdaq Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Capital Nasdaq is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with FrontView REIT, and Capital Nasdaq

The main advantage of trading using opposite FrontView REIT, and Capital Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Capital Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capital Nasdaq will offset losses from the drop in Capital Nasdaq's long position.

The idea behind FrontView REIT, and Capital Nasdaq Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.